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Introduction 
Sputum is one of the most commonly received 
specimens in the microbiology laboratory. However, 
the authors are unaware of previously published data 
on how useful sputum, sent for bacterial culture, is in 
general practice. This paper reports the impact of 
positive and negative sputum reports on patient 
management using two questionnaires circulated to 
local general practitioners (GPs). 
Methods and Results 
From November 1993 to March 1994, all sputa 
received from GPs were surveyed. Sputa received in 
the Public Health Laboratory, Nottingham are 
Gram-stained, cultured for Haemophilus infuenzae 
and other recognized respiratory pathogens, and 
appropriate antibiotic sensitivities are carried out and 
reported. During the study period, 300 specimens 
were received from 13 1 GPs (a mean of 2.3 specimens 
per GP). When each result was posted to the GP, a 
questionnaire was included which enquired about 
why the sputum was taken, recent antibiotic treat- 
ment, and how the result might influence that 
patient’s management. 
Seventy-five (25%) sputa grew recognized or 
potential respiratory pathogens. These included 
H. injknzae (39 sputa), Streptococcus pneumoniae 
(19 sputa), Staphylococcus aureus (5 sputa), Pseudo- 
monas aeruginosa (6 sputa), Branhamella catarrhalis 
(2 sputa) and others (8 sputa). The remaining 225 
specimens were all cultured and yielded only respira- 
tory commensals. Two hundred and sixty-four of the 
questionnaires (88%) were returned, 253 of which 
were suitable for analysis. Reasons for sending a 
sputum sample included: failure of one or more 
antibiotics (136 sputa); chronic lung disease (36 
sputa); ‘to exclude infection’ (27 sputa); and recent 
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sputum production or a significant cough (34 sputa). 
Patients had already been on antibiotics in the pre- 
vious 3 weeks in 149 of the 253 cases, and 38 (25%) 
of these had positive sputum culture. The possible 
influence of the result on antibiotic prescribing and 
general patient management is outlined in Table 1. 
The report was deemed helpful on 210 occasions, 
95% of positive and 79% of negative reports. 
Ninety-seven GPs returned a second questionnaire 
sent at the end of the study, relating to general 
aspects of the sputum-reporting service. Antibiotic 
sensitivity results were considered the most useful 
part of the report by 52 GPs, and culture results, by 
30 GPs. Reports were received early enough to 
influence management by 68 of 97 (70%) GPs. Thirty- 
four GPs were reluctant to send a sputum once a 
patient had started antibiotics, but 32 GPs indicated 
they would be happy to do so. 
Discussion 
These results show considerable variation in the 
usage of sputum microbiology by GPs but the study 
did not investigate the reasons why most of the 500 
GPs in this catchment area do not avail of this 
service. Not surprisingly, two-thirds of GPs were less 
likely to send sputa for culture when the patient was 
already on antibiotics, but a significantly high 
number of specimens taken in such circumstances 
(26%), yielded a respiratory pathogen. Furthermore, 
antibiotic prescribing was influenced on 116 occa- 
sions following a negative culture result, i.e. the GP 
decided not to use antibiotics or they were stopped. 
Following a positive culture result, nearly one-half of 
cases had an antibiotic changed or started. Thirty 
percent of GPs, however, considered the reports did 
not arrive soon enough to influence management. 
The possible issuing of reports by computer or by 
facsimile in future may improve this. 
The difficulties in evaluating antibiotic therapy in 
exacerbations of chronic bronchitis are well- 
documented (1) and a positive result following 
therapy in the light of clinical improvement may 
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Table I Effect of bacterial culture results on antibiotic use 
and patient management 
Positive Negative 
culture culture 
(n=62) (?l= 191) 
Antibiotic use 
Continued 
Changed 
Discontinued 
Started 
No antibiotics started 
Not stated 
General management 
Patient reassured 
No action 
For further investigations 
Unevaluable/not stated 
23 (37%) 60 (32%) 
7 (11%) 6 (3%) 
1 (2%) 12 (6%) 
23 (37%) 4 (2%) 
8 (13%) 104 (54%) 
0 5 (3%) 
6 (10%) 98 (52%) 
17 (27%) 29 (15%) 
6 (10%) 25 (13%) 
33 (53%) 39 (20%) 
represent residual colonization (2). In the U.K., the 
majority of bacterial isolates will be sensitive to 
amoxycillin. Alternatively co-amoxyclav or an oral 
cephalosporin with good activity against Haemo- 
philus may be recommended, especially if the patient 
has recently been on amoxycillin. However, there is 
no national consensus of microbiologists on the 
subject that the authors are aware of. The decision to 
continue antibiotics following a negative culture on 
60 occasions as well as the failure to use antibiotics 
on eight occasions following a positive culture may 
indicate a need for more rational prescribing. It is 
concluded that a considerable proportion of GPs 
who send sputa for culture find the results helpful in 
clinical decision-making. Greater use of this service 
and improvements in reporting times might result in 
better use of antibiotics in the management of lower 
respiratory tract infection in the community. 
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